1 Day
Source:
The Boston Globe
The Boston Globe
Ready to play
Ready to play
Researchers are developing a vaccine targeting bacteria associated with acne, aiming to provide a long-term, effective treatment that could reduce dependence on creams and medications. Sanofi is testing an mRNA-based vaccine in clinical trials, while another approach by UC San Diego involves neutralizing enzymes produced by acne-causing bacteria. If successful, these vaccines could significantly improve skin health and offer new insights into managing inflammatory skin conditions.
Notice: This Is an AI-Generated Summary
Comments (0)